Estrogen receptor alpha deletion enhances the metastatic phenotype of Ron overexpressing mammary tumors in mice

Molecular Cancer

Volumn 11, Issue , 2012, Pages

  Marshall, Aaron M ^a   McClaine, Rebecca J ^a   Gurusamy, Devikala ^a   Gray, Jerilyn K ^a   Lewnard, Kara E ^a   Khan, Sohaib A ^a   Waltz, Susan E ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Estrogen receptor; Hepatocyte growth factor like protein; MST1R; Ron receptor

Indexed keywords

CYCLIN D1; ESTROGEN RECEPTOR ALPHA; MEMBRANE PROTEIN; PROTEIN RON; SMAD3 PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG; PROTEIN TYROSINE KINASE; RON PROTEIN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE DELETION; GENOTYPE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; METASTASIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; C57BL MOUSE; EXPERIMENTAL NEOPLASM; GENE EXPRESSION; GENETICS; METABOLISM; MORTALITY; NUDE MOUSE; PATHOLOGY;

MURINAE; MUS; MUS MUSCULUS;

ANIMALS; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE DELETION; GENE EXPRESSION; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, NUDE; MICE, TRANSGENIC; NEOPLASM METASTASIS; NEOPLASM STAGING; PHENOTYPE; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 84855471912     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-11-2     Document Type: Article

References (37)

1. Palazzo A, Iacovelli R, Cortesi E. Past, present and future of targeted therapy in solid tumors. Curr Cancer Drug Targets 2010, 10:433-461. 10.2174/156800910791517145, 20384576.
2. Clarke R, Leonessa F, Welch JN, Skaar TC. Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol Rev 2001, 53:25-71.
3. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995, 270:1491-1494. 10.1126/science.270.5241.1491, 7491495.
4. McClaine RJ, Marshall AM, Wagh PK, Waltz SE. Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines. Neoplasia 2010, 12:650-658. 2915409, 20689759.
5. Arpino G, De Angelis C, Giuliano M, Giordano A, Falato C, De Laurentiis M, De Placido S. Molecular mechanism and clinical implications of endocrine therapy resistance in breast cancer. Oncology 2009, 77(Suppl 1):23-37.
6. Britton DJ, Hutcheson IR, Knowlden JM, Barrow D, Giles M, McClelland RA, Gee JM, Nicholson RI. Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth. Breast Cancer Res Treat 2006, 96:131-146. 10.1007/s10549-005-9070-2, 16261397.
7. Meijer D, van Agthoven T, Bosma PT, Nooter K, Dorssers LC. Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells. Mol Cancer Res 2006, 4:379-386. 10.1158/1541-7786.MCR-05-0156, 16778085.
8. Shou J, Massarweh S, Osborne CK, Wakeling AE, Ali S, Weiss H, Schiff R. Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. J Natl Cancer Inst 2004, 96:926-935. 10.1093/jnci/djh166, 15199112.
9. Wagh PK, Peace BE, Waltz SE. Met-related receptor tyrosine kinase Ron in tumor growth and metastasis. Adv Cancer Res 2008, 100:1-33.
10. Meyer SE, Zinser GM, Stuart WD, Pathrose P, Waltz SE. The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesis. Dev Biol 2009, 333:173-185. 10.1016/j.ydbio.2009.06.028, 2728205, 19576199.
11. Peace BE, Hughes MJ, Degen SJ, Waltz SE. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis. Oncogene 2001, 20:6142-6151. 10.1038/sj.onc.1204836, 11593422.
12. Chen YQ, Zhou YQ, Fu LH, Wang D, Wang MH. Multiple pulmonary adenomas in the lung of transgenic mice overexpressing the RON receptor tyrosine kinase. Recepteur d'origine nantais. Carcinogenesis 2002, 23:1811-1819. 10.1093/carcin/23.11.1811, 12419829.
13. Zinser GM, Leonis MA, Toney K, Pathrose P, Thobe M, Kader SA, Peace BE, Beauman SR, Collins MH, Waltz SE. Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation. Cancer Res 2006, 66:11967-11974. 10.1158/0008-5472.CAN-06-2473, 17178895.
14. Peace BE, Toney-Earley K, Collins MH, Waltz SE. Ron receptor signaling augments mammary tumor formation and metastasis in a murine model of breast cancer. Cancer Res 2005, 65:1285-1293. 10.1158/0008-5472.CAN-03-3580, 15735014.
15. Maggiora P, Marchio S, Stella MC, Giai M, Belfiore A, De Bortoli M, Di Renzo MF, Costantino A, Sismondi P, Comoglio PM. Overexpression of the RON gene in human breast carcinoma. Oncogene 1998, 16:2927-2933. 10.1038/sj.onc.1201812, 9671413.
16. Daniel CW, Silberstein GB, Strickland P. Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res 1987, 47:6052-6057.
17. Fan P, Wang J, Santen RJ, Yue W. Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells. Cancer Res 2007, 67:1352-1360. 10.1158/0008-5472.CAN-06-1020, 17283173.
18. Feng Y, Manka D, Wagner KU, Khan SA. Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice. Proc Natl Acad Sci USA 2007, 104:14718-14723. 10.1073/pnas.0706933104, 1976199, 17785410.
19. Silberstein GB, Van Horn K, Shyamala G, Daniel CW. Essential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure antiestrogens. Endocrinology 1994, 134:84-90. 10.1210/en.134.1.84, 8275973.
20. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:518-524. 10.1038/nature03799, 1283098, 16049480.
21. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B, et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 2006, 98:262-272. 10.1093/jnci/djj052, 16478745.
22. Wagh PK, Gray JK, Zinser GM, Vasiliauskas J, James L, Monga SP, Waltz SE. beta-Catenin is required for Ron receptor-induced mammary tumorigenesis. Oncogene 2011,
23. Thobe MN, Gurusamy D, Pathrose P, Waltz SE. The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells. Oncogene 2010, 29:214-226. 10.1038/onc.2009.331, 2806938, 19838218.
24. Torres-Arzayus MI, Font de Mora J, Yuan J, Vazquez F, Bronson R, Rue M, Sellers WR, Brown M. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 2004, 6:263-274. 10.1016/j.ccr.2004.06.027, 15380517.
25. Augereau P, Miralles F, Cavailles V, Gaudelet C, Parker M, Rochefort H. Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Mol Endocrinol 1994, 8:693-703. 10.1210/me.8.6.693, 7935485.
26. Lin Z, Reierstad S, Huang CC, Bulun SE. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer. Cancer Res 2007, 67:5017-5024. 10.1158/0008-5472.CAN-06-3696, 17510434.
27. Sabbah M, Courilleau D, Mester J, Redeuilh G. Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. Proc Natl Acad Sci USA 1999, 96:11217-11222. 10.1073/pnas.96.20.11217, 18014, 10500157.
28. Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 2004, 96:906-920. 10.1093/jnci/djh164, 15199110.
29. Russo J, Russo IH. The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 2006, 102:89-96. 10.1016/j.jsbmb.2006.09.004, 1832080, 17113977.
30. Ren Y, Wu L, Frost AR, Grizzle W, Cao X, Wan M. Dual effects of TGF-beta on ERalpha-mediated estrogenic transcriptional activity in breast cancer. Mol Cancer 2009, 8:111. 10.1186/1476-4598-8-111, 2787496, 19943940.
31. Mizuochi T, Yee ST, Kasai M, Kakiuchi T, Muno D, Kominami E. Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain. Immunol Lett 1994, 43:189-193. 10.1016/0165-2478(94)90221-6, 7721331.
32. Liu QP, Fruit K, Ward J, Correll PH. Negative regulation of macrophage activation in response to IFN-gamma and lipopolysaccharide by the STK/RON receptor tyrosine kinase. J Immunol 1999, 163:6606-6613.
33. Nikolaidis NM, Gray JK, Gurusamy D, Fox W, Stuart WD, Huber N, Waltz SE. Ron receptor tyrosine kinase negatively regulates TNFalpha production in alveolar macrophages by inhibiting NF-kappaB activity and Adam17 production. Shock 2010, 33:197-204. 10.1097/SHK.0b013e3181ae8155, 19487969.
34. de la Haba J, Gomez A, Duenas R, Ribelles N, Mendez MJ, Serrano R, Font P, Aranda E. The quotient of number of nodes and tumour size (N/T) from primary breast cancer predicts the clinical course after diagnosis of distant relapse. Eur J Surg Oncol 2004, 30:346-351. 10.1016/j.ejso.2003.10.006, 15028320.
35. Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 2007, 608:1-22. 10.1007/978-0-387-74039-3_1, 17993229.
36. Wagner KU, McAllister K, Ward T, Davis B, Wiseman R, Hennighausen L. Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res 2001, 10:545-553. 10.1023/A:1013063514007, 11817542.
37. Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, Garrett L, Li M, Furth PA, Hennighausen L. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res 1997, 25:4323-4330. 10.1093/nar/25.21.4323, 147032, 9336464.